Lasa M, Brook M, Saklatvala J, Clark A R
Kennedy Institute of Rheumatology Division, Imperial College School of Medicine, Hammersmith, London W6 8LH, United Kingdom.
Mol Cell Biol. 2001 Feb;21(3):771-80. doi: 10.1128/MCB.21.3.771-780.2001.
The stability of cyclooxygenase 2 (Cox-2) mRNA is regulated positively by proinflammatory stimuli acting through mitogen-activated protein kinase (MAPK) p38 and negatively by anti-inflammatory glucocorticoids such as dexamethasone. A tetracycline-regulated reporter system was used to investigate mechanisms of regulation of Cox-2 mRNA stability. Dexamethasone was found to destabilize beta-globin-Cox-2 reporter mRNAs by inhibiting p38. This inhibition occurred at the level of p38 itself: stabilization of reporter mRNA by a kinase upstream of p38 was blocked by dexamethasone, while stabilization by a kinase downstream of p38 was insensitive to dexamethasone. Inhibition of p38 activity by dexamethasone was observed in a variety of cell types treated with different activating stimuli. Furthermore, inhibition of p38 was antagonized by the anti-glucocorticoid RU486 and was delayed and actinomycin D sensitive, suggesting that ongoing glucocorticoid receptor-dependent transcription is required.
环氧化酶2(Cox-2)信使核糖核酸(mRNA)的稳定性受到促炎刺激的正向调节,这种调节通过丝裂原活化蛋白激酶(MAPK)p38起作用;同时也受到抗炎性糖皮质激素(如地塞米松)的负向调节。利用四环素调控的报告系统来研究Cox-2 mRNA稳定性的调控机制。研究发现,地塞米松通过抑制p38使β-珠蛋白-Cox-2报告mRNA不稳定。这种抑制作用发生在p38本身的水平:p38上游激酶对报告mRNA的稳定作用被地塞米松阻断,而p38下游激酶的稳定作用对地塞米松不敏感。在用不同激活刺激处理的多种细胞类型中均观察到地塞米松对p38活性的抑制作用。此外,抗糖皮质激素RU486可拮抗对p38的抑制作用,且这种抑制作用出现延迟并对放线菌素D敏感,这表明需要持续进行糖皮质激素受体依赖性转录。